참고문헌
- Bhurgri Y, Shaheen Y, Kayani N, et al (2011). Incidence, trends and morphology of ovarian cancer in Karachi (1995-2002). Asian Pac J Cancer Prev, 12, 1567-71.
- Biete A, Valduvieco I, Rovirosa A, et al (2010). Whole abdominal radiotherapy in ovarian cancer. Rep Pract Oncol Radiother, 15, 27-30. https://doi.org/10.1016/j.rpor.2010.02.004
- Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002). Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol, 20, 1248-59. https://doi.org/10.1200/JCO.20.5.1248
- Brown AP, Jhingran A, Klopp AH, et al(2013). Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol, 130, 300-5. https://doi.org/10.1016/j.ygyno.2013.04.469
- Chang JS, Koom WS, Kim SW, et al(2013). Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy. J Gynecol Oncol, 24, 146-53. https://doi.org/10.3802/jgo.2013.24.2.146
- Corn BW, Lanciano RM, Boente M, et al (1994). Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure. Cancer, 74, 2979-83. https://doi.org/10.1002/1097-0142(19941201)74:11<2979::AID-CNCR2820741114>3.0.CO;2-B
- De Meerleer G, Vandecasteele K, Ost P, et al (2011). Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapyresistant ovarian cancer with bulky peritoneal disease: a single-institution experience. Int J Radiat Oncol Biol Phys, 79, 775-81. https://doi.org/10.1016/j.ijrobp.2009.11.039
- Dembo AJ (1992). Epithelial ovarian cancer: the role of radiotherapy. Int J Radiat Oncol Biol Phys, 22, 835-45. https://doi.org/10.1016/0360-3016(92)90777-F
- Dembo AJ, Bush RS (1982). Choice of postoperative therapy based on prognostic factors. Int J Radiat Oncol Biol Phys, 8, 893-7. https://doi.org/10.1016/0360-3016(82)90096-7
- Dembo AJ, Bush RS, Beale FA, et al (1979). Improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am J Obstet Gynecol, 134, 793-800. https://doi.org/10.1016/0002-9378(79)90950-5
- Eltabbakh GH, Goodrich S (2006). Update on the treatment of recurrent ovarian cancer. Womens Health (Lond Engl), 2, 127-39. https://doi.org/10.2217/17455057.2.1.127
- Gocheva L (2003). Whole abdomen irradiation in epithelial ovarian cancer - state of the art. Wspotczesna Onkologia, 13, 181-90.
- Hoskins PJ, Le N, Gilks B, et al (2012). Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation. J Clin Oncol, 30, 1656-62. https://doi.org/10.1200/JCO.2011.40.1646
- Kobel M, Kalloger SE, Huntsman DG, et al (2010). Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol, 29, 203-11. https://doi.org/10.1097/PGP.0b013e3181c042b6
- Kojs Z, Glinski B, Reinfuss M, et al (2001). Results of a randomized prospective trial comparing postoperative abdominopelvic radiotherapy with postoperative chemotherapy in early ovarian cancer. Cancer Radiother, 5, 5-11. https://doi.org/10.1016/S1278-3218(00)00022-6
- Mahantshetty U, Jamema S, Engineer R, et al (2010). Whole abdomen radiation therapy in ovarian cancers: a comparison between fixed beam and volumetric are based intensity modulation. Radiat Oncol, 15, 106.
- Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A (2009). Changing trends in incidence of ovarian cancer - the Indian scenario. Asian Pac J Cancer Prev, 10, 1025-30.
- Nagai Y, Inamine M, Hirakawa M, et al (2007). Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary. Gynecol Oncol, 107, 469-73. https://doi.org/10.1016/j.ygyno.2007.07.079
- Ozols RF (1997): Controversies in the management of ovarian cancer. Int J Gynecol Cancer, 7, 27-32.
- Quon M, Gallant V, Samant R (2006). Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer. Gynecol Oncol, 102, 204-9. https://doi.org/10.1016/j.ygyno.2005.11.047
- Rochet N, Kieser M, Sterzing F, et al (2011). Phase II study evaluating consolidation whole abdominal intensitymodulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study. BMC Cancer, 28, 11-41.
- Rochet N, Sterzing F, Jensen AD, et al (2010). Intensitymodulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study. Int J Radiat Oncol Biol Phys, 76, 1382-9. https://doi.org/10.1016/j.ijrobp.2009.03.061
- Shetty UM, Shankar S, Engineer R, et al (2013). Image guided intensity modulated whole abdomen radiation therapy in relapsed epithelial ovarian cancers: a feasibility study. J Can Res Ther, 9, 17-21. https://doi.org/10.4103/0973-1482.110343
- Sirichaisutdhikorn D, Suprasert P, Khunamornpong S (2009). Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin. Asian Pac J Cancer Prev, 10, 1041-5.
- Sorbe B (2003). Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer, 13, 276-8.
- Suprasert P, Manopunya M, Cheewakriangkrai C (2014). Outcomes with single agent LIPO-DOX in platinumresistant ovarian and fallopian tube cancers and primary peritoneal adenocarcinoma - Chiang Mai University Hospital Experience. Asian Pac J Cancer Prev, 15, 1145-8. https://doi.org/10.7314/APJCP.2014.15.3.1145
- Swenerton KD, Santos JL, Gilks CB, et al (2011). Histotype predicts the curative potential of radiotherapy: The example of ovarian cancers. Ann Oncol, 22, 341-7. https://doi.org/10.1093/annonc/mdq383
- Thomas G (2013). Revisiting the role of radiation treatment for non-serous subtypes of epithelial ovarian cancer. Am Soc Clin Oncol Educ Book, 31, e205.
- Yahara K, Ohguri T, Imada H, et al (2013). Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy. J Radiat Res, 54, 322-9. https://doi.org/10.1093/jrr/rrs108
피인용 문헌
- Evaluation of Effects of Metformin in Primary Ovarian Cancer Cells vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.6973
- Prevalence of Anxiety May Not be Elevated in Thai Ovarian Cancer Patients Following Treatment vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1251
- XIAP Associated Factor 1 (XAF1) Represses Expression of X-linked Inhibitor of Apoptosis Protein (XIAP) and Regulates Invasion, Cell Cycle, Apoptosis, and Cisplatin Sensitivity of Ovarian Carcinoma Cells vol.16, pp.6, 2015, https://doi.org/10.7314/APJCP.2015.16.6.2453
- Prognostic values of 5-hmC, 5-mC and TET2 in epithelial ovarian cancer vol.292, pp.4, 2015, https://doi.org/10.1007/s00404-015-3704-3
- Fractionated Palliative Pelvic Radiotherapy as an Effective Modality in the Management of Recurrent/Refractory Epithelial Ovarian Cancers: An Institutional Experience vol.67, pp.2, 2017, https://doi.org/10.1007/s13224-016-0926-7
- Impact on survival with adjuvant radiotherapy for clear cell, mucinous, and endometriod ovarian cancer: the SEER experience from 2004 to 2011 vol.27, pp.5, 2016, https://doi.org/10.3802/jgo.2016.27.e45